Illinois Court Rules for Defendant in Prenatal Monitoring Patent Dispute
Was möchten Sie als Nächstes tun?
Wählen Sie Ihren Weg entsprechend Ihren aktuellen Bedürfnissen:
📋 Fallzusammenfassung
| Fallbezeichnung | Fitch, Even, Tabin and Flannery, LLP v. Dorsey et al. |
| Fallnummer | 1:25-cv-03141 |
| Gericht | US-Bezirksgericht für den nördlichen Bezirk von Illinois |
| Dauer | Mar 2025 – Feb 2026 335 Days (~11 Months) |
| Ergebnis | Defendant Win — No Damages |
| Streitige Patente | |
| Beschuldigte Produkte | Prenatal physiological monitoring apparatus and method |
Fallübersicht
Die Parteien
⚖️ Kläger
A well-established Chicago-based intellectual property law firm with a long-standing reputation in patent prosecution and IP portfolio management.
🛡️ Beklagter
Aligned with the development or commercialization of prenatal monitoring technology, with Prenatal-Hope, Inc. focused on maternal-fetal health.
Das streitige Patent
This litigation centered on **U.S. Patent No. US11622705B2**, covering an *apparatus and method for determining physiological parameters of an infant in-utero* — a technology with meaningful implications for prenatal care innovation and the competitive medical monitoring market.
- • US11622705B2 — Apparatus and method for non-invasively determining physiological parameters of an infant in-utero
Developing a prenatal monitoring device?
Check for potential infringement before launch with PatSnap Eureka’s FTO tools.
Das Urteil und die rechtliche Analyse
Ergebnis
The court entered a verdict **in favor of defendants Tammy E. Dorsey, James R. Balman, and Prenatal-Hope, Inc.**, and against plaintiff Fitch, Even, Tabin and Flannery, LLP. No damages were awarded to the plaintiff. This outcome underscores critical lessons for patent prosecutors, IP litigators, and R&D teams operating in the medtech space.
Wichtige rechtliche Fragen
The verdict favoring the defendants could stem from a finding of non-infringement, invalidity of the asserted claims (e.g., due to anticipation, obviousness, or enablement issues), or a procedural ruling. The case involved a granted utility patent (US11622705B2) with claims scope around in-utero physiological parameter measurement, where claim construction battles frequently center on the scope of method steps and apparatus limitations in medtech.
Freedom to Operate (FTO) Analysis in Prenatal Monitoring
This case highlights crucial IP risks in the rapidly evolving prenatal monitoring sector. Choose your next step:
📋 Die Auswirkungen dieses Falls verstehen
Learn about the specific risks and implications from this litigation for medtech.
- View the patent family of US11622705B2
- See which companies are active in fetal monitoring patents
- Understand claim construction patterns in medtech
🔍 Das Risiko meines Produkts überprüfen
Run a comprehensive FTO analysis for your own medical device or technology.
- Geben Sie Ihre Produktbeschreibung oder technischen Merkmale ein.
- AI identifies potentially blocking patents in medtech
- Erhalten Sie einen umsetzbaren Risikobewertungsbericht
Hochrisikogebiet
In-utero physiological monitoring methods
Single Patent
US11622705B2 at issue
Efficient Resolution
Case closed in 335 days
✅ Wichtigste Erkenntnisse
Defendant-favorable verdicts in infringement actions can arise from non-infringement, invalidity, or procedural grounds — each requiring distinct litigation preparation.
Verwandte Rechtsprechung suchen →The 335-day resolution suggests early dispositive motion practice; study this docket for efficient defense frameworks.
Präzedenzfälle erkunden →Häufig gestellte Fragen
The case centered on U.S. Patent No. US11622705B2 (Application No. US17/555256), covering an apparatus and method for determining physiological parameters of an infant in-utero.
The specific basis of termination was not disclosed in publicly available case data. The verdict in favor of defendants Dorsey, Balman, and Prenatal-Hope, Inc. may reflect a finding of non-infringement, patent invalidity, or a procedural ruling. Full analysis requires review of the PACER docket for case 1:25-cv-03141.
The outcome signals that infringement assertions in the fetal monitoring space are contestable and that defendants with strong technical and legal defenses can prevail even against experienced IP plaintiff firms.
Sind Sie bereit, Ihre Patentstrategie zu stärken?
Schließen Sie sich den über 18.000 Fachleuten aus dem Bereich des geistigen Eigentums an, die PatSnap Eureka nutzen, um mit KI-gestützter Präzision Recherchen zum Stand der Technik durchzuführen, Patentanmeldungen zu erstellen und Wettbewerbslandschaften zu analysieren.
Referenzen
- PACER — U.S. District Court for the Northern District of Illinois, Case 1:25-cv-03141
- USPTO Patent Center — U.S. Patent No. US11622705B2
- Cornell Legal Information Institute — 35 U.S. Code Patent Laws
- PatSnap – Lösungen für den Umgang mit geistigem Eigentum für Anwaltskanzleien
Dieser Artikel dient ausschließlich zu Informationszwecken und stellt keine Rechtsberatung dar. Alle Angaben zu den Fällen stammen aus öffentlich zugänglichen Gerichtsakten. Informationen zu den Funktionen der Plattform finden Sie auf PatSnap.